Skip to content

The Role of Endothelium Dysfunction in Progression of CKD (Chronic Kidney Disease) After AKI (Acute Kidney Injury)

The Role of Endothelium Dysfunction in Progression of CKD (Chronic Kidney Disease) After AKI (Acute Kidney Injury)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00358306
Enrollment
36
Registered
2006-07-31
Start date
2008-04-30
Completion date
2009-07-31
Last updated
2020-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Renal Failure, Chronic Kidney Failure, Endothelial Dysfunction, Hemolytic-uremic Syndrome (HUS)

Keywords

Endothelium, Chronic Kidney Disease, Acute Kidney Injury, Hemolytic-uremic syndrome (HUS)

Brief summary

To understand how AKI (Acute Kidney Injury) leads to chronic kidney disease so therapies can be found to alter the progression of events thereby significantly impacting the long-term outcomes of children who develop AKI.

Detailed description

This research study is designed to study what happens to the kidneys after they have an injury. There is some evidence that even if there appears to be great improvement of kidney function, an injury can put patients at risk for long-term problems with their kidney function and increase their risk to have high blood pressure. We want to collect information from participants to help explain why this injury can cause future problems, including Chronic Kidney Disease (CKD) which may help us prevent these health problems.

Interventions

None listed

Sponsors

University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
2 Years to 20 Years
Healthy volunteers
Yes

Inclusion criteria

* Children between age 2-20 * Decrease in renal function by 25% or greater * Renal function has returned to normal

Exclusion criteria

* History of chronic disease * Cancer * Congenital heart disease * Organ Transplantation * Liver disease * Pulmonary disease * Diabetes other primary metabolic condition * Severe neurologic impairments * Hypertension * Auto-immune * Infectious disease or renal disease * Smokers * Renal disease w/primary cause i.e. - HUS or Glomerulonephritis * severe allergies including allergy to seafood and/or iodine

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026